TITLE

Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model

AUTHOR(S)
Assi, Tina-Marie; Brown, Shawn T.; Djibo, Ali; Norman, Bryan A.; Rajgopal, Jayant; Welling, Joel S.; Chen, Sheng-I.; Bailey, Rachel R.; Kone, Souleymane; Kenea, Hailu; Connor, Diana L.; Wateska, Angela R.; Jana, Anirban; Wisniewski, Stephen R.; Van Panhuis, Willem G.; Burke, Donald S.; Lee, Bruce Y.
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p425
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Many countries, such as Niger, are considering changing their vaccine vial size presentation and may want to evaluate the subsequent impact on their supply chains, the series of steps required to get vaccines from their manufacturers to patients. The measles vaccine is particularly important in Niger, a country prone to measles outbreaks. Methods: We developed a detailed discrete event simulation model of the vaccine supply chain representing every vaccine, storage location, refrigerator, freezer, and transport device (e.g., cold trucks, 4 × 4 trucks, and vaccine carriers) in the Niger Expanded Programme on Immunization (EPI). Experiments simulated the impact of replacing the 10-dose measles vial size with 5-dose, 2-dose and 1-dose vial sizes. Results: Switching from the 10-dose to the 5-dose, 2-dose and 1-dose vial sizes decreased the average availability of EPI vaccines for arriving patients from 83% to 82%, 81% and 78%, respectively for a 100% target population size. The switches also changed transport vehicle's utilization from a mean of 58% (range: 4-164%) to means of 59% (range: 4-164%), 62% (range: 4-175%), and 67% (range: 5-192%), respectively, between the regional and district stores, and from a mean of 160% (range: 83-300%) to means of 161% (range: 82-322%), 175% (range: 78-344%), and 198% (range: 88-402%), respectively, between the district to integrated health centres (IHC). The switch also changed district level storage utilization from a mean of 65% to means of 64%, 66% and 68% (range for all scenarios: 3-100%). Finally, accounting for vaccine administration, wastage, and disposal, replacing the 10-dose vial with the 5 or 1-dose vials would increase the cost per immunized patient from $0.47US to $0.71US and $1.26US, respectively. Conclusions: The switch from the 10-dose measles vaccines to smaller vial sizes could overwhelm the capacities of many storage facilities and transport vehicles as well as increase the cost per vaccinated child.
ACCESSION #
62668289

 

Related Articles

  • Plunging MMR uptake leaves UK close to endemic measles. Clarke-Jones, Joanna // Pulse;11/10/2003, Vol. 63 Issue 45, p4 

    Reports on the results of the research on the use of measles, mumps, and rubella (MMR) vaccination in Great Britain. Decline of the MMR vaccination; Influence of the decline on the increased measles cases; Possibility of a measles epidemic during the winter of 2003.

  • A Field Trial of Combined Measles-Mumps-Rubella Vaccine. Borgoño, J. Manuel; Greiber, Rosa; Solari, Giovanna; Concha, Fresia; Carrillo, Blanca; Hilleman, Maurice R. // Clinical Pediatrics;Mar1973, Vol. 12 Issue 3, p170 

    This report presents confirming evidence for the immunizing value of a trivalent combined measles-mumps-rubella vaccine (M-M-R), based on studies with 188 children in Chile. All of the children developed antibody against measles virus and 96 per cent developed antibodies against mumps and...

  • The Status of Measles Vaccines.  // Clinical Pediatrics;May1963, Vol. 2 Issue 5, p217 

    Presents a statement on the status of measles vaccines and recommendations for their use issued by the United States Surgeon General's Advisory Committee on Measles Control in 1963. Live Attenuated measles virus vaccine (Edmonston strain); Inactivated measles virus vaccine; Combinations of...

  • Measles vaccines-A positive step toward eradicating a negative strand. Arvin, Ann M. // Nature Medicine;Jul2000, Vol. 6 Issue 7, p744 

    Focuses on development of measles DNA vaccines that may prevent the complications associated with non-infectious vaccine approaches. Results from the use of the vaccine for the children over the age of 9 months; Effectiveness of the vaccine in young infants; Significance of a macaque model of...

  • National Campaign to Eliminate Rubella and Strengthen Measles Elimination in Haiti.  // Immunization Newsletter;2009, Vol. 31 Issue 4, p1 

    The article reports on the implementation of the national vaccination campaign to eliminate rubella and measles in Haiti. It states that Pan American Health Organization (PAHO) and Haiti joined in adopting the goal of rubella and congenital rubella syndrome (CRS) elimination by 2010. It notes...

  • No Long-term Excess Mortality after Measles Infection: A Community Study from Senegal. Aaby, Peter; Samb, Badara; Andersen, Marc; Simondon, Francois // American Journal of Epidemiology;1996, Vol. 143 Issue 10, p1035 

    Because measles immunization has been found in all studies to reduce mortality with more than the share of deaths attributed to acute measles, the authors examined mortality after measles infection in a study in a rural area of Senegal that included 6,924 unimmunized children, of whom 1,118...

  • Less Measles--Really Down This Time? Polk, Lewis D. // Clinical Pediatrics;Apr1975, Vol. 14 Issue 4, p321 

    The article discusses measles. In 1967, the Federal Government stated that a program involving measles immunization and surveillance could wipe out the disease. Initially, the trend was in the direction of these optimistic hopes. The number of cases in the United States decreased each year to a...

  • Cost-effectiveness of Supplementary Immunization for Measles in India. DABRAL, MAYANK // Indian Pediatrics;Nov2009, Vol. 46 Issue 11, p957 

    Objective: This study aims to estimate the incremental cost effectiveness of a supplementary immunization activity (SIA) for measles in a district of India with measles vaccine coverage equivalent to the National average. Design: A state transition model is used to estimate the effect of routine...

  • Measles on the Decline.  // Clinical Pediatrics;Aug1965, Vol. 4 Issue 8, p435 

    The article reports on the 220,165 measles cases reported in the U.S. as of June 19, 1965. The effect of the use of measles vaccines on the number of cases reported cannot be determined yet.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics